Datadog New AI Agents To Enhance Application Issue Resolution
Datadog's new domain-specific AI agents, unveiled at DASH, are each trained to be experts in incident response, product development and security. The agents are built on a flexible system of shared tasks—core capabilities such as querying data, analysing anomalies or scaling infrastructure that can be reused across agents. The architecture allows Datadog to build and deploy new agents quickly while maintaining a consistent and powerful user experience. This is combined with expansive, high-quality observability data, enabling Datadog's AI capabilities to operate with context and precision, and deliver insights and actions to eliminate risk.
'Datadog is uniquely positioned to deliver value with AI as a platform that has a wealth of clean, rich data—we process trillions of data points and are embedded in our customers' critical engineering, developer and security workflows,' said Yanbing Li, Chief Product Officer at Datadog. 'With these advancements in AI reasoning and multi-modality, we've gone beyond helping organisations understand their availability, security, performance and reliability. We now enable human-in-the-middle workflows by guiding customers on what to look for and where to start looking, and augment their ability to take action.'
The new AI agents announced at DASH are:
Bits AI SRE, a 24x7 on-call responder that is now in Limited Availability. For all alerts, Bits AI SRE performs early triage using telemetry and service context to surface initial investigation findings all before responders log in. It assigns appropriate owners, aligns all parties with real-time incident summaries and status updates, and proactively suggests next steps. It also generates a first draft of the incident post-mortem to save responders time.
Bits AI Dev Agent, now in Preview, which detects issues, generates code fixes, and opens pull requests tailored to organisations' technology stack to allow users to quickly review and merge changes directly within their SCM. As a result, engineers don't just have software that surfaces errors—they have an AI teammate that helps fix the issue and improve productivity for human resources.
Bits AI Security Analyst, which autonomously triages Cloud SIEM (security information and event management) signals, conducts in-depth investigations of potential threats and delivers reasoned resolution recommendations without human prompting. Bits AI Security Analyst, now in Preview, automates investigations and reduces response times, fundamentally transforming how organisations process security signals.
'At Thomson Reuters, we're focused on maximising operational efficiency and accelerating innovation at scale through generative AI solutions,' said Darren Trzynka, Senior Cloud Architect at Thomson Reuters. 'Bits AI allows operations and downstream platform teams to receive the full context of the investigation—from the initial monitor trigger to conclusion—driving down resolution time significantly freeing them up to do more.'
Additional Applied AI capabilities in preview include:
Proactive App Recommendations, which continuously analyses telemetry Datadog already collects to suggest high-impact fixes and the next best action. Whether it's optimising a slow query, addressing inefficient code paths or catching recurring exceptions, APM Recommendations shows developers exactly where to improve performance, reduce errors and cut down resource usage—all before users are affected.
APM Investigator, to help engineers troubleshoot and resolve latency spikes faster. It automates a previously manual process by identifying bottlenecks, scoping impact, highlighting patterns across slow traces, suggesting likely causes and proposing a fix.
To learn more about Datadog's latest Applied AI capabilities, please visit: https://www.datadoghq.com/product/platform/bits-ai/.
Bits AI SRE, Bits AI Dev Agent, Bits AI Security Analyst, Proactive App Recommendations and APM Investigator were announced during the DASH keynote. The replay is available here. During DASH, Datadog also announced launches in AI Observability, AI Security, Log Management and released its .
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
NZ Herald
2 hours ago
- NZ Herald
Kiwi crime-fighting software firm Auror gets big tick from UK Govt, medtech Formus Labs nears commercial launch in the US
Cooper said she wanted more UK retailers to use Auror's software, which aims to make it easier for retailers to report offences to police, including photos, and snippets of video taken on their cameras. The Home Secretary is urging police to make greater use of facial recognition technology and is behind the bill, currently winding its way through the UK Parliament. The controversial bill makes it an offence to conceal your identity from CCTV under certain circumstances (including protests), introduces the new offence of assaulting a retail worker and makes theft from a shop trial-able, regardless of the value of the goods (from a £200 [$450] threshold today). Stores including M&S, Morrisons, Boots, Tesco, Primark, and Greggs are submitting CCTV, photos and personal data on all their repeat shoplifters to Auror's platform, which is shared with police. Cooper endorsed the Kiwi software after receiving a briefing from Boots, according to the UK's Telegraph. Auror executives Mark Gleeson and Paul Fagg were invited to 10 Downing St last month - UK Prime Minister Keir Starmer's residence - for what the Herald understands was a meeting with officials. Photo / LinkedIn Additionally, two Auror executives were recently invited to 10 Downing Street: UK and Europe vice president Mark Gleeson (a former tactical commander with the Royal Air Force) and UK director of law enforcement and partnerships Paul Fagg (who began his career as a police constable for London's Metro Police and rose to become a police inspector with the National Business Crime Centre before joining Auror last year). Fagg said his firm's crime intelligence platform enabled retailers to record everything that happens in their stores to tackle the 'huge under-reporting issue'. 'Police have access to Auror so that incidents they did not see before are now visible for them,' he said, adding that this enabled police and retailers to identify prolific offenders with CCTV and photographic evidence. Auror uses templates to speed up and standardise retail crime reporting. The shared data enables all the stores and police to 'join the dots' to identify prolific offenders, gather evidence for prosecutions and provide security staff on the shop doors with photo watchlists to bar entry, Fagg said. Auror says its system is used by 98% of retailers in NZ and 75% in Australia. In November last year, the Kiwi firm raised $82m at a $500m valuation, with the funds earmarked, in part, for a push to further expand in the US. Phil Thomson hadn't worked in retail or software before cofounding Auror. He worked for a big law firm, specialising in intellectual property and privacy issues. The raise was led by two new investors: Axon Enterprise (formerly Taser International) and W23, a venture fund backed by five retailers including Tesco and Woolworths. Nasdaq-listed Axon – which has a US$70 billion ($115b) market cap – invented the Taser in the 1970s. In the 2000s it expanded into bodycams, then computer-aided dispatch software and a cloud-based digital evidence platform. The firm was already an Auror technology partner. Going harder with Taser maker in the US On June 4, Axon and Auror announced a new Retail Crime Hub, which they billed as 'unlocking a more efficient way for North American law enforcement agencies to collaborate with retailers and stop crime in our communities'. Auror already had a substantial beachhead in the US through anchor customer Walmart, founder Phil Thomson said. Thomson says the issue goes well beyond shoplifting: "Retail crime isn't victimless - it's violence, it's assault, and it's organised". The new Retail Crime Hub should help it extend its reach. Thomson said a key issue was that while NZ has a single law enforcement authority (the police) dealing with retail crime, in the US it varied not just by state but by locality with some 18,000 agencies at the country level. Auror is pitched as a conduit to link them together for intel on retail crimes that fly well under the radar of national enforcement agencies. The privacy debate The fast-growing Auror has drawn a degree of privacy flak on both sides of the Tasman with a system that uses digital images which can misidentify people. But the firm has kept its nose clean with our Privacy Commissioner. Thomson emphasises that Auror doesn't operate any security cameras and does not offer live facial recognition. Privacy Commissioner Michael Webster recently gave facial recognition trials by our two major supermarket chains his cautious tick of approval. And Justice Minister Paul Goldsmith says the option of having a centralised system of facial recognition is something he expects officials to consider. 'We [Auror] acknowledge the calls from groups like Retail NZ, the UK Home Secretary, and NZ Government, for the use of technology such as facial recognition technology [FRT] in the retail sector,' Thomson told Tech Insider earlier today. 'We support the responsible use of FRT by retailers to protect workers, shoppers and communities from violence and harm.' Thomson knows the legal and philosophical ins-and-outs (he's a former intellectual property lawyer with Simpson Grierson and an ex-board member of the public-interest focused NZ Council of Legal Education). But he says his support for FRT is based on what's happening every day in the real world. 'With retail violence continuing to rise, it's a no-brainer for retailers to explore how this technology [FRT] can be responsibly used in their stores. It's already used in everyday environments such as airports, hotels and casinos,' he says. 'Due to the increase in violence and crime in stores, in my view, it's now not a matter of 'if' or 'when' - it's about 'how' this can be deployed in the best way possible, protecting communities while also protecting privacy. 'Retail crime isn't victimless - it's violence, it's assault, and it's organised. We know one in 10 events involve violence or use of a weapon. Ten % of top repeat offenders are responsible for more than 60% of the crime in Kiwi stores. Furthermore, repeat offenders are up to four times more likely to be violent.' Hip to be AI: Formus Labs poised for US commercial launch Formus Labs' AI-powered, 3D planning software for joint replacement surgeries. Photo / Supplied Auckland-based med-tech Formus Labs will commercially launch in the key US market in a couple of months, founder and chief executive Dr Ju Zhang says. The launch follows the start-up gaining US Food and Drug Administration approval in December for its AI-powered, 3D software for planning orthopaedic surgeries - specifically hip replacements, with its FDA green light. Formus is lining up deals with the likes of hospital chains and insurance firms. Zhang says his firm has pilots already under way with several 'tier one' and 'tier two' players - with revenue above US$1 billion ($1.65b) or in the hundreds of millions, respectively. Formus Labs founder Dr Ju Zhang. Photo/Supplied The start-up already has a close relationship with one of the biggest names in the field - Indiana-based Zimmer Biomet, which invested US$5m ($8.25m) in the Kiwi firm in early 2022 (the round was also supported by existing local investors including Icehouse Ventures, Pacific Channel, Punakaiki Fund and Global From Day 1). Zhang says with major commercial revenue just months away, there are no plans for another sizeable raise, though it's possible Formus will stage a small round for bridging. The FDA approval was a breakthrough moment as many regulators around the world take their lead from the US agency, Zhang says. Japan - a major market for partner Zimmer - will be next cab-off-the-rank for the multi-Hi-Tech Awards winner. Members of the Formus Labs team, still based in NZ as the firm pushes into the US and Japan. Australia is also a major market. Zhang says Formus consults closely with several orthopaedic surgeons in NZ but commercial maths means the primary focus has been across the Tasman and in North America. Regardless, he and his crew of 16 staff are based in Auckland, which he anticipated will remain the hub of the firm's R&D. There's a lot that's high-tech about joint replacement surgery these days. But there's also a lot of drilling, scraping, sawing and hammering. 'In some ways, it's a lot like carpentry,' Zhang says. Formus Lab's software helps a surgeon more quickly and accurately prepare, and pick the right size joint replacement from what can run into hundreds of options. Currently one in 10 operations have to be redone and five out of 10 have some degree of post-op complication. Medtech on the rise At a HealthTech Week event in Auckland last week, the audience heard that New Zealand's MedTech sector currently generates around $2.6b in annual revenue and is projected to reach $3.8b by 2028, a compound annual growth rate of 7.8% since 2018, according to Technology Investment Network, TIN200 stats. 'It's still dominated by the big fish; the likes of F&P Healthcare,' Callaghan Innovation HealthTech head Andrew Clews told Tech Insider. 'But there is a second tier of companies coming through now that we're supporting.' Clews says venture capital money is coming on board and the number of start-ups is increasing - thanks in part to a tight-knit ecosystem. Formus Labs is one of several medtechs spun out of Auckland University's Bioengineering Institute, for example, he said. Others include Kitea Health, the maker of a world-first wireless implant for measuring brain pressure, Toku Eyes and Alimetry. The event was arranged by Te Tītoki Mataora, funded by Auckland University and MBIE and Callaghan Innovation's HealthTech Activator. Both programmes offer various forms of support for medtech start-ups, although Callaghan Innovation is being disestablished. With most staff already laid off, the HealthTech Activator has funding to last through until a new advanced research agency is created around this time next year. Chris Keall is an Auckland-based member of the Herald's business team. He joined the Herald in 2018 and is the technology editor and a senior business writer.
NZ Herald
4 days ago
- NZ Herald
What Wall Street's rampaging run means for KiwiSaver investors
This week, the S&P 500 and Nasdaq hit record highs, boosted by gains in technology stocks and a trade agreement between the United States and Vietnam. The Dow Jones Industrial Average is only a fraction short of its record close on December 4. Followers of the US Federal Reserve will
Scoop
5 days ago
- Scoop
Healthcare's GenAI Gold Rush Is Here, But The Infrastructure Isn't Ready
Modernisation of legacy IT systems remains critical to meeting data security, privacy, and scalability demands for healthcare organisations Nutanix (NASDAQ: NTNX), a leader in hybrid multicloud computing, announced the findings of its seventh annual global Healthcare Enterprise Cloud Index (ECI) survey and research report, which measures enterprise progress with cloud adoption in the industry. The research showed that 99% of healthcare organisations surveyed are currently leveraging GenAI applications or workloads today, more than any other industry. This includes a mix of applications from AI-powered chatbots to code co-pilots and clinical development automation. However, the overwhelming majority (96%) share that their current data security and governance measures are insufficient to fully support GenAI at scale. 'In healthcare, every decision we make has a direct impact on patient outcomes - including how we evolve our technology stack,' said Jon Edwards, Director IS Infrastructure Engineering at Legacy Health. 'We took a close look at how to integrate GenAI responsibly, and that meant investing in infrastructure that supports long-term innovation without compromising on data privacy or security. We're committed to modernising our systems to deliver better care, drive efficiency, and uphold the trust that patients place in us.' This year's report revealed that healthcare leaders are adopting GenAI at record rates while concerns remain. The number one issue flagged by healthcare leaders is the ability to integrate it with existing IT infrastructure (79%) followed closely by the fact that healthcare data silos still exist (65%), and development challenges with cloud native applications and containers (59%) are persistent. 'While healthcare has typically been slower to adopt new technologies, we've seen a significant uptick in the adoption of GenAI, much of this likely due to the ease of access to GenAI applications and tools,' said Scott Ragsdale, Senior Director, Sales - Healthcare & SLED at Nutanix. 'Even with such large adoption rates by organisations, there continue to be concerns given the importance of protecting healthcare data. Although all organisations surveyed are using GenAI in some capacity, we'll likely see more widespread adoption within those organisations as concerns around privacy and security are resolved.' Healthcare survey respondents were asked about GenAI adoptions and trends, Kubernetes and containers, how they're running business and mission critical applications today, and where they plan to run them in the future. Key findings from this year's report include: GenAI solution adoption and deployment across healthcare will necessitate a more comprehensive approach to data security. Healthcare respondents indicate a significant amount of work needs to be done to improve the foundational levels of data security/governance required to support GenAI solution implementation and success. The No. 1 challenge faced by healthcare organisations when it comes to leveraging or expanding utilisation of GenAI is privacy and security concerns of using large language models (LLMs) with sensitive company data. Furthermore, 96% of healthcare respondents agree that their organisation could be doing more to secure their GenAI models and applications. Improving data security and governance at the scale needed to support emerging GenAI workloads will be a long-term challenge and priority for many healthcare organisations. Prioritise infrastructure modernisation to support GenAI at scale across healthcare organisations. Running modern applications at enterprise scale requires infrastructure solutions that can support the necessary requirements for complex data security, data integrity and resilience. Unfortunately, 99% of healthcare respondents admit they face challenges when scaling GenAI workloads from development to production – with the No. 1 issue being integration with existing IT infrastructure. For this reason, we believe it is imperative that healthcare IT decision-makers prioritise infrastructure investments and modernisation as a key enabling component of GenAI initiatives. GenAI solution adoption in the healthcare sector continues at a rapid pace, but there are still challenges to overcome. When it comes to GenAI adoption, healthcare metrics are excellent, with 99% of industry respondents saying their organisation is leveraging GenAI applications/workloads today. Most healthcare organisations believe GenAI solutions will help improve levels of productivity, automation, and efficiency. Meanwhile, real-world GenAI use cases across healthcare segments gravitate towards GenAI-based customer support and experience solutions (e.g., chatbots), and code generation and code co-pilots. However, healthcare organisations also note a range of challenges and potential hindrances regarding GenAI solution development and deployment, including patient data security and privacy, scalability, and complexity. Application containerisation and Kubernetes® deployments are expanding across the healthcare industry. Container-based infrastructure and application development has the potential to allow organisations to deliver seamless, secure access to patient and business data across hybrid and multicloud environments. Application containerisation is pervasive across industry sectors and is set to expand in adoption across healthcare as well, with 99% of industry respondents saying their organisation is at least in the process of containerising trend may be driven by the fact that 92% of healthcare respondents agree their organisation benefits from adopting cloud native applications/containers. These findings suggest that the majority of IT decision-makers in healthcare will be considering how containerisation fits into expansion strategies for new and existing workloads. For the seventh consecutive year, Nutanix commissioned a global research study to learn about the state of global enterprise cloud deployments, application containerisation trends, and GenAI application adoption. In the Fall of 2024, U.K. researcher Vanson Bourne surveyed 1,500 IT and DevOps/Platform Engineering decision-makers around the world. The respondent base spanned multiple industries, business sizes, and geographies, including North and South America; Europe, the Middle East and Africa (EMEA); and Asia-Pacific-Japan (APJ) region. To learn more about the report and findings, please download the full Healthcare Nutanix Enterprise Cloud Index, here and read the blog here. About Nutanix Nutanix is a global leader in cloud software, offering organizations a single platform for running applications and managing data, anywhere. With Nutanix, companies can reduce complexity and simplify operations, freeing them to focus on their business outcomes. Building on its legacy as the pioneer of hyperconverged infrastructure, Nutanix is trusted by companies worldwide to power hybrid multicloud environments consistently, simply, and cost-effectively. Learn more at or follow us on social media @nutanix.
